Location: Home
  • search
  • go
  • Relate News
  • 7/10/2012CDE Releases Review of Drug Registration Evaluation in the First Half
  • 7/10/2012Center for Drug Evaluation Issues Two More Rules
  • 7/9/2012Roche Drugs under EU Investigation Trigger Questions in China
  • 7/9/2012Walvax Acquires Majority Control of Shanghai Fengmao Biotech for Entry...
  • 7/9/2012Southern Research Center for Viral Diseases Established
  • 7/9/2012Guangzhou Establishes Food and Drug Criminal Investigation Force
  • 7/9/2012China Increases Its Activity in Regulated Markets
  • 7/6/2012ShangPharma Chairman Offers to Take the Company Private
  • 7/6/2012Analysts Expects Renewed Pharma Industry Growth in the Second Half
  • 7/6/2012Phase III Clinical Trials of Rh-Apo2L Completed Successfully
  • 7/5/2012New Study Finds Diabetes Prevalence in Chinese Teens Four Times Higher...
  • 7/5/2012Sanofi Plans to Slash Research and Manufacturing Positions in France
  • 7/4/2012China Moves to Promote CNY Convertibility
  • 7/4/2012BMS Acquires Amylin as GSK Extends Offer for Human Genome Sciences
  • 7/4/2012Biospectrum: Asia Pacific Bioscience Industry Growth Slows
  • 7/4/2012Beike Biotech Reports Effectiveness of Stem Cell Treatment for PBC
  • 7/4/2012Emerging Lessons from the Emerging Markets (External)
  • 7/4/2012Upcoming Event: Healthcare in China
  • 7/4/2012MOH Points Directions at Recent Drug Policy and EDS Conference
  • 7/4/2012Japanese Pharma Companies Step Up Market Expansion in China
  • 7/4/2012Pfizer and Hisoar Enter into 20-Year Supply Agreement for Clindamycin
  • 7/4/2012Pharma Gets Social: China - Pharma's Social Media Frontier (External)
  • 7/4/2012Recent Executive Moves
  • 7/3/2012Upcoming Event: Health of a Nation: New Prescriptions for China
  • 7/3/2012SFDA Solicits Comments on "Guidelines for Electronic Supervision ...
  • 7/3/2012Pharma Industry Performance Up Considerably in the First Five Months
  • 7/2/2012MOHRSS Releases 2011 Statistics for HR and Social Security Development
  • 7/2/2012SFDA Seeks Comments on Draft Rule on Risk Assessment for Onsite Inspec...
  • 7/2/2012CMOs and Final Dosage Manufacturing in China (External)
  • 6/29/2012Chinese Government to Fund New Drug Innovation with CNY 115B by 2020
  • Page:482/720 Total number of articles:21572: [First][<<] [480] [481] [482] [483] [484] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group